II 

115TH CONGRESS 

1ST SESSION S. 920 

To establish a National Clinical Care Commission. 

IN THE SENATE OF THE UNITED STATES 

APRIL 24, 2017 

Mrs. SHAHEEN (for herself and Ms. COLLINS) introduced the following bill; 

which was read twice and referred to the Committee on Health, Education, Labor, and Pensions 

A BILL 

To establish a National Clinical Care Commission. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘National Clinical Care 

5 Commission Act’’. 

6 SEC. 2. NATIONAL CLINICAL CARE COMMISSION. 

7 (a) ESTABLISHMENT.—There is hereby established, 

8 within the Department of Health and Human Services, 

9 a National Clinical Care Commission (in this section re10 ferred to as the ‘‘Commission’’) to evaluate and make rec11 ommendations regarding improvements to the coordinaVerDate Sep 11 2014 22:55 Apr 24, 2017 Jkt 069200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S920.IS S920

sradovich on DSK3GMQ082PROD with BILLS
2 

•S 920 IS

1 tion and leveraging of programs within the Department 

2 and other Federal agencies related to awareness and clin3 ical care for at least one, but not more than two, complex 

4 metabolic or autoimmune diseases resulting from issues 

5 related to insulin that represent a significant disease bur6 den in the United States, which may include complications 

7 due to such diseases. 

8 (b) MEMBERSHIP.— 

9 (1) IN GENERAL.—The Commission shall be 

10 composed of the following voting members: 

11 (A) The heads of the following Federal 

12 agencies and departments, or their designees: 

13 (i) The Centers for Medicare & Med14 icaid Services. 

15 (ii) The Agency for Healthcare Re16 search and Quality. 

17 (iii) The Centers for Disease Control 

18 and Prevention. 

19 (iv) The Indian Health Service. 

20 (v) The Department of Veterans Af21 fairs. 

22 (vi) The National Institutes of 

23 Health. 

24 (vii) The Food and Drug Administra25 tion. 


sradovich on DSK3GMQ082PROD with BILLS
3 

•S 920 IS

1 (viii) The Health Resources and Serv2 ices Administration. 

3 (ix) The Department of Defense. 

4 (x) The Department of Agriculture. 

5 (xi) The Office of Minority Health. 

6 (B) Twelve additional voting members ap7 pointed under paragraph (2). 

8 (2) ADDITIONAL MEMBERS.—The Commission 

9 shall include additional voting members, as may be 

10 appointed by the Secretary, with expertise in the 

11 prevention, care, and epidemiology of any of the dis12 eases and complications described in subsection (a), 

13 including one or more such members from each of 

14 the following categories: 

15 (A) Physician specialties, including clinical 

16 endocrinologists, that play a role in the preven17 tion or treatment of diseases and complications 

18 described in subsection (a). 

19 (B) Primary care physicians. 

20 (C) Non-physician health care profes21 sionals. 

22 (D) Patient advocates. 

23 (E) National experts, including public 

24 health experts, in the duties listed under sub25 section (c). 


sradovich on DSK3GMQ082PROD with BILLS
4 

•S 920 IS

1 (F) Health care providers furnishing serv2 ices to a patient population that consists of a 

3 high percentage (as specified by the Secretary) 

4 of individuals who are enrolled in a State plan 

5 under title XIX of the Social Security Act or 

6 who are not covered under a health plan or 

7 health insurance coverage. 

8 (3) CHAIRPERSON.—The members of the Com9 mission shall select a chairperson from the members 

10 appointed under paragraph (2). 

11 (4) MEETINGS.—The Commission shall meet at 

12 least twice, and not more than four times, a year. 

13 (5) VACANCIES.—A vacancy on the Commission 

14 shall be filled in the same manner as the original ap15 pointments. 

16 (c) DUTIES.—The Commission shall evaluate and 

17 make recommendations, as appropriate, to the Secretary 

18 of Health and Human Services and Congress regarding— 

19 (1) Federal programs of the Department of 

20 Health and Human Services that focus on pre21 venting and reducing the incidence of the diseases 

22 and complications described in subsection (a); 

23 (2) current activities and gaps in Federal ef24 forts to support clinicians in providing integrated, 


sradovich on DSK3GMQ082PROD with BILLS
5 

•S 920 IS

1 high-quality care to individuals with the diseases and 

2 complications described in subsection (a); 

3 (3) the improvement in, and improved coordina4 tion of, Federal education and awareness activities 

5 related to the prevention and treatment of the dis6 eases and complications described in subsection (a), 

7 which may include the utilization of new and exist8 ing technologies; and 

9 (4) methods for outreach and dissemination of 

10 education and awareness materials that— 

11 (A) address the diseases and complications 

12 described in subsection (a); 

13 (B) are funded by the Federal Govern14 ment; and 

15 (C) are intended for health care profes16 sionals and the public. 

17 (d) OPERATING PLAN.—Not later than 90 days after 

18 its first meeting, the Commission shall submit to the Sec19 retary of Health and Human Services and the Congress 

20 an operating plan for carrying out the activities of the 

21 Commission as described in subsection (c). Such operating 

22 plan may include— 

23 (1) a list of specific activities that the Commis24 sion plans to conduct for purposes of carrying out 


sradovich on DSK3GMQ082PROD with BILLS
6 

•S 920 IS

1 the duties described in each of the paragraphs in 

2 subsection (c); 

3 (2) a plan for completing the activities; 

4 (3) a list of members of the Commission and 

5 other individuals who are not members of the Com6 mission who will need to be involved to conduct such 

7 activities; 

8 (4) an explanation of Federal agency involve9 ment and coordination needed to conduct such ac10 tivities; 

11 (5) a budget for conducting such activities; and 

12 (6) other information that the Commission 

13 deems appropriate. 

14 (e) FINAL REPORT.—By not later than 3 years after 

15 the date of the Commission’s first meeting, the Commis16 sion shall submit to the Secretary of Health and Human 

17 Services and the Congress a final report containing all of 

18 the findings and recommendations required by this sec19 tion. 

20 (f) SUNSET.—The Commission shall terminate 60 

21 days after submitting its final report, but not later than 

22 the end of fiscal year 2021. 

Æ 


sradovich on DSK3GMQ082PROD with BILLS